IL-17 Signaling Links Psoriasis to Cardiometabolic Risk, Review Finds
A new review identifies IL-17 signaling as the mechanistic link between psoriasis and cardiometabolic risk, connecting plaque biology with vascular and metabolic disease.
Topic
Topic
A new review identifies IL-17 signaling as the mechanistic link between psoriasis and cardiometabolic risk, connecting plaque biology with vascular and metabolic disease.